Transgenomic, Inc. (TBIO) Announces $22.0 Million Private Placement Financing

2/3/2012 6:57:01 AM

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2012 revenue of $32.2 million, up 18% compared to revenue of $27.2 million in the same period of fiscal 2011 and GAAP net income of $2.9 million, or $0.07 per diluted share compared to a GAAP net loss of $0.8 million or a loss of $0.02 per basic and diluted share in the prior year.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Transgenomic, Inc.

• Medical Devices

• Medical Dev. & Diag. - Alliances

• Medical Dev. & Diag. - Finance

• Medical Dev. & Diag. - Investor